Dupilumab
EFC18366
Phase 3 small_molecule active
Quick answer
Dupilumab for Lichen Simplex Chronicus is a Phase 3 program (small_molecule) at Regeneron UK Limited with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Regeneron UK Limited
- Indication
- Lichen Simplex Chronicus
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active